The influence of neuronal electrical activity on the mammalian central clock metabolome by Buijink, M.R. et al.
Vol.:(0123456789) 
Metabolomics (2018) 14:122 
https://doi.org/10.1007/s11306-018-1423-z
ORIGINAL ARTICLE
The influence of neuronal electrical activity on the mammalian central 
clock metabolome
M. Renate Buijink1 · Michel van Weeghel1,2 · M. Can Gülersönmez2 · Amy C. Harms2 · Jos H. T. Rohling1 · 
Johanna H. Meijer1 · Thomas Hankemeier2 · Stephan Michel1
Received: 10 May 2018 / Accepted: 31 August 2018 / Published online: 17 September 2018 
© The Author(s) 2018
Abstract
Introduction Most organisms display circadian rhythms in physiology and behaviour. In mammals, these rhythms are 
orchestrated by the suprachiasmatic nucleus (SCN). Recently, several metabolites have emerged as important regulators of 
circadian timekeeping. Metabolomics approaches have aided in identifying some key metabolites in circadian processes in 
peripheral tissue, but methods to routinely measure metabolites in small brain areas are currently lacking.
Objective The aim of the study was to establish a reliable method for metabolite quantifications in the central circadian clock 
and relate them to different states of neuronal excitability.
Methods We developed a method to collect and process small brain tissue samples (0.2 mm3), suitable for liquid chroma-
tography–mass spectrometry. Metabolites were analysed in the SCN and one of its main hypothalamic targets, the paraven-
tricular nucleus (PVN). Tissue samples were taken at peak (midday) and trough (midnight) of the endogenous rhythm in 
SCN electrical activity. Additionally, neuronal activity was altered pharmacologically.
Results We found a minor effect of day/night fluctuations in electrical activity or silencing activity during the day. In contrast, 
increasing electrical activity during the night significantly upregulated many metabolites in SCN and PVN.
Conclusion Our method has shown to produce reliable and physiologically relevant metabolite data from small brain samples. 
Inducing electrical activity at night mimics the effect of a light pulses in the SCN, producing phase shifts of the circadian 
rhythm. The upregulation of metabolites could have a functional role in this process, since they are not solely products of 
physiological states, they are significant parts of cellular signalling pathways.
Keywords Circadian clock metabolites · Suprachiasmatic nucleus · Neuronal activity · Small brain samples · ZIC-
cHILIC-MS
1 Introduction
Almost all organisms express circadian rhythms in physiol-
ogy and behaviour defined by a period of about 24 h. In 
mammals, these circadian rhythms are controlled by the 
suprachiasmatic nucleus (SCN), a small brain area located 
just above the optic chiasm (Moore and Eichler 1972; Ste-
phan and Zucker 1972). The SCN is synchronized to the 
24-h environmental cycle mainly by light. In the absence 
of external cues like light or temperature cycles, the neu-
ronal network of the SCN sustains an autonomous circadian 
rhythm in electrical activity and neurotransmitter release 
(Gillette and Reppert 1987; Nishino et al. 1976). These sig-
nals from the SCN serve as a temporal reference for the 
rest of the body and orchestrate circadian rhythms through-
out the brain and body, including sleep-wake cycles (Ibuka 
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and Kawamura 1975; Moore 2007), food intake and energy 
metabolism (Coomans et al. 2013; Kalsbeek et al. 2011; 
Nagai et al. 1978). Disturbances in circadian rhythms have 
been found to be associated with many diseases, including 
metabolic syndrome (Rudic et al. 2004; Turek et al. 2005) 
and neurodegenerative diseases (Ju et al. 2013; Kondratova 
and Kondratov 2012; Musiek et al. 2015; Wulff et al. 2010).
Neurons in the SCN exhibit robust autonomous rhythmic-
ity, which is controlled on several levels. There are known 
intracellular oscillators on the level of gene expression, cyto-
sol and electrical activity. First, on the level of gene expres-
sion, the “molecular clock”—consisting of clock genes and 
proteins—constitutes a well-described core transcription-
translation feedback loop (TTFL), which has a cycle time of 
about 24 h (Sangoram et al. 1998). Second, in addition to the 
TTFL there are several cytosolic oscillators like  Ca2+, cAMP 
and redox state (Ikeda et al. 2003; O’Neill et al. 2008; Wang 
et al. 2012). The redox oscillator is well-preserved among 
species and is considered to be a link between metabolic 
state, and both the molecular clock and membrane excitabil-
ity (Wang et al. 2012). Lastly, an essential part of the SCN 
clockwork is the electrical activity of SCN neurons. Elec-
trical activity modifies the molecular clock and vice versa 
and this interaction between membrane and clock genes is 
essential for sustained rhythm generation (Allen et al. 2017; 
Colwell 2011).
Neurons in the SCN are electrically active during the day, 
and relatively silent during the night in both diurnal and 
nocturnal animals (Inouye and Kawamura 1979; Sato and 
Kawamura 1984). One of the main targets for the SCN activ-
ity is the paraventricular nucleus (PVN) of the hypothala-
mus, which receives both paracrine as well as GABAergic 
and glutamatergic input from the SCN, and controls feeding 
behaviour and plasma glucose level (Kalsbeek et al. 2004; 
Santoso et al. 2017; Tousson and Meissl 2004). While the 
rhythm in electrical activity of extra-SCN areas in the hypo-
thalamus has been found to be reversed in phase, the only 
study that directly measured electrical activity in the PVN 
has found the electrical activity rhythm to be in phase with 
the SCN (Inouye and Kawamura 1979; Kubota et al. 1981; 
Tousson and Meissl 2004).
Metabolites are products of cellular regulatory processes, 
and their relative levels are therefore indicative of the meta-
bolic state of a cell. They are an attractive target to study 
since they are identical across species, and organisms differ 
less in their metabolome than in their genome or proteome. 
Several metabolites, such as cAMP (O’Neill et al. 2008), and 
metabolic pathways, such as the pentose phosphate pathway 
(Rey et al. 2016) are considered to be relevant for proper 
functioning of the circadian clockwork. Metabolomics has 
proven to be useful to study circadian clock function in liver 
and blood of mice (Eckel-Mahan et al. 2012; Minami et al. 
2009), and has been applied to blood samples of humans 
to investigate the effect of sleep deprivation (Davies et al. 
2014). However, until now there are no metabolomics stud-
ies of specific brain areas like the SCN, an important con-
straint being their small size, especially in commonly used 
animal models such as the mouse. Although there are com-
plex techniques to measure metabolites with mass spectrom-
etry in small samples, and even single cells (Lapainis et al. 
2009; Qi et al. 2018), more generally applicable methods 
for small tissue samples are lacking. Therefore, we aimed to 
design a suitable method for tissue sampling and metabolite 
extraction for the analysis of metabolites with liquid chroma-
tography–mass spectrometry (LC–MS) in small brain areas 
(Fig. 1). Using this method, we have studied the metabolic 
profiles of the SCN, as well as the PVN—a first relay area 
to control many physiological functions. We were interested 
in endogenous differences between day and night, as well as 
the effect of exogenously modulating neuronal activity on 
the metabolic profile of these brain areas.
Since we expected differences in energy metabolism, we 
focused our analytical approach on small polar metabolites, 
including metabolites from the TCA cycle, glycolysis, pen-
tose phosphate and nucleotide pathways. For the metabolic 
profiling of the SCN and the PVN we used zwitterionic 
hydrophilic interaction liquid chromatography mass spec-
trometry (ZIC-cHILIC-MS), which is especially suitable for 
the analysis of anionic polar metabolites in complex aqueous 
matrices. In this study we show that it is feasible to meas-
ure metabolites in very small tissue samples (0.2 mm3). We 
could reliably measure and identify 35 metabolites in SCN 
and PVN tissue. We found only one metabolite (malate) 
significantly upregulated in the day compared to the night 
condition. Exposure to high extracellular  K+ at midnight 
upregulated many of the metabolites measured in SCN and 
PVN tissue, including all metabolites of the TCA cycle.
2  Method
2.1  Animals and housing
This study was performed in accordance with the Dutch 
law on animal welfare. The permit was issued by the ani-
mal experiments committee Leiden (DEC 12250). Male 
C57BL/6 mice were held in the animal facility of the Lei-
den University Medical Center, with food and water avail-
able ad libitum. Mice were kept in 24-h light–dark cycles 
with 12 h of light (50–100 lx; Osram truelight TL) and 
12 h of darkness. Mice were approximately 3 months old 
(84–91 days) at the time of the experiments.
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2.2  SCN and PVN tissue sampling
For the collection of SCN and PVN tissue, mice were sac-
rificed either an hour before midday (ZT6) or midnight 
(ZT18). The mice were fasted for 4 h before the start of the 
experiment. After decapitation, the brain was quickly dis-
sected and placed in ice cold, low  Ca2+ and high  Mg2+ artifi-
cial cerebral spinal fluid (ACSF), containing (in mM): NaCl 
(116.4), KCl (5.4),  NaH2PO4 (1.0),  MgSO4 (0.8),  CaCl2 
(1.0),  MgCl2 (4.0),  NaHCO3 (23.8), d-glucose (15.1) and 
5 mg/L gentamicin (Sigma Aldrich) saturated with 95%  O2 
− 5%  CO2 (pH 7.4). From each individual animal, two con-
secutive coronal slices of 250 µm were cut with a VT 1000S 
vibratome (Leica). The brain slices were incubated for an 
hour in either normal ACSF containing 2 mM CaCl2 and no 
 MgCl2 (ZT6; ZT18), or normal ACSF with TTX (0.5 µM; 
ZT6) or higher levels of  K+ (15 mM; ZT18), at room tem-
perature (n = 6 for all groups). This method, including the 
incubation in ACSF is widely used as preparation for physi-
ological experiments on SCN tissue (Nakamura et al. 2012; 
Michel et al. 2013). Slices were kept cold while collect-
ing the SCN and PVN punches within a few minutes after 
incubation. We collected bilateral punches of Ø 500 µm 
(sample corer, 19-gauge, Fine Science Tools; adapted from 
Lee et al. 2010), from two consecutive slices, resulting in 4 
punches of both the SCN and PVN, with a total volume of 
Fig. 1  Overview of tissue 
sampling and processing. a 
For extraction and measure-
ments of metabolites in SCN 
and PVN tissue, the brain was 
first isolated from the mouse, 
and the hypothalamic region, 
containing the SCN was cut 
in 250 µm thick slices. These 
slices were incubated in ACSF, 
or ACSF with either 0.5 µM 
TTX or 15 mM  K+. b After 
incubation, the SCN and PVN 
were extracted from the slices 
by a sample corer. Because 
of the tight control over the 
thickness of the slices (250 µm) 
and the diameter of the punch 
(500 µm), the volume of the 
sample was constant (0.2 
 mm3). Punches were placed 
in 50/50 methanol/water and 
directly snap frozen in  N2. 
Samples were kept at − 80 C 
until metabolite extraction. c 
Metabolites were extracted 
from the tissue by using a 
liquid–liquid extraction method 
with 100 µL chloroform added 
to the 100 µL 50/50 methanol/
water. Samples were homog-
enized in an ice-cold sonication 
bath for 3 × 10 min. Between 
sonication, samples were snap 
frozen for a short period in  N2. 
Proteins were cleared from the 
solution by centrifuging. The 
top layer was transferred to a 
clean 0.5 mL tube and dried 
in a vacuum concentrator. d 
The dried samples were then 
reconstituted in 20 µL of 60/40 
methanol/water and analysed by 
liquid chromatography through 
a ZIC-cHILIC column, followed 
by mass spectrometry
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0.2  mm3 from one animal per sample. This standardized and 
reproducible volume rendered weighing the samples unnec-
essary. Punches were directly placed in 100 µL ice cold 
50/50 methanol/H2O containing 5 µM of internal standards 
(succinic acid-D4, 13C5-valine, 13C4-15N2-asparagine, 
13C5-glutamine and 15N2-UMP), and snapfrozen in liquid 
nitrogen (adapted from Nemes et al. 2011). The combination 
of methanol and snapfreezing ensured adequate quenching 
of enzymatic activity, is suitable for metabolite extraction, 
and can be used for the ZIC-cHILIC column. Samples were 
stored at − 80 °C until further processing. Figure 1b shows a 
bright field and a bioluminescence image from a brain slice 
with one of the two SCN cores removed by punch.
2.3  Metabolite extraction
Metabolites were extracted using a combination of chemical 
and mechanical techniques (Fig. 1b, c). First, a liquid–liq-
uid extraction (LLE) was performed by adding 100 µL of 
chloroform to the samples in methanol–water. Samples were 
vortexed, then sonicated in an ice-cold sonication bath for 
10 min, followed by snapfreezing in liquid nitrogen. This 
procedure was repeated 3 times. The samples were then cen-
trifuged for 10 min at 14.000 g at 4 °C to remove proteins 
from the solution. Before and after the sonication and cen-
trifuging, samples were kept on ice. From the 100 µL polar 
top layer 80 µL was transferred to a 1.5 mL tube and dried 
in a vacuum concentrator (Labconco, MO, USA) for 3 h. 
The samples were reconstituted in 20 µL of methanol/H2O 
solution (60/40).
2.4  Metabolite analysis
Metabolites were analysed using liquid chromatography fol-
lowed by mass spectrometry. For the analysis, an Agilent 
1200 ultra-high-pressure liquid chromatography system 
(Agilent technologies, Santa Clara, CA, USA) coupled to 
a SCIEX TripleTOF 5600 quadrupole-time-of-flight mass 
spectrometer (Framingham, MA, USA) was used. Samples 
were kept at 10 °C in the autosampler and 5 µL of sample 
was injected on the analytical column. The chromatographic 
separation was established using a SeQuant ZIC-cHILIC 
column (PEEK 100 × 2.1 mm, 3.0 µm particle size; Merck 
KGaA, Darmstadt, Germany), which was kept at 15 °C 
using a column thermostat (560-CIL, Cleuzeau Info Labo, 
France). The flow rate was 0.2 mL/min. The mobile phases 
where composed of (A) 90/10 acetonitrile/H2O with 5 mM 
ammonium acetate at pH 6.8 and (B) 10/90 acetonitrile/
H2O with 5 mM ammonium acetate at pH 6.8, respectively. 
Metabolites were separated using a gradient composed of 
100% A for 3 min; ramping 3–20 min to 36% A; ramping 
28–28.5 to 100% A and re-equilibrated from 28.5 to 36 min 
with 100% A. The MS data was acquired at full scan range 
50–800 amu at a scan rate of 10 scans/s in negative ionisa-
tion mode and the source temperature was kept at 400 °C.
2.5  Data analysis and statistics
The metabolite peaks were integrated using MultiQuan Soft-
ware v3.0 (SCIEX, Framingham, MA, USA). The responses 
of the targeted metabolites were corrected for the response 
of a selected internal standard. Statistical analysis was 
performed using GraphPad Prism 6 (Graphpad, La Jolla, 
CA, USA) and statistical programming language R (http://
www.r-proje ct.org), with packages ‘mixOmics’ (Rohart et al. 
2017) for the PLS-DA, and ‘gplots’ (https ://cran.r-proje 
ct.org/packa ge=gplot s) to visualize the heatmaps. Differ-
ences in individual metabolites were evaluated using a one-
way analysis of variance (ANOVA) with a Tukey post-hoc 
correction for multiple comparisons. A P value of < 0.05 
was considered significant.
3  Results
3.1  ZIC‑cHILIC‑MS optimization for SCN and PVN
The ZIC-cHILIC-MS method was partly adapted from a 
previous application of the ZIC-cHILIC column for serum 
metabolite profiling of colorectal tumor patients (Zhu et al. 
2014) and modified for the measurement of anionic polar 
metabolites in SCN and PVN samples. For the sensitive 
measurement of the anionic polar metabolites in these sam-
ples, we optimized the extraction procedure for small sample 
sizes as described in Sect. 2. After metabolite extraction 
from the SCN and PVN, we were able to semi-quantitatively 
determine 35 anionic polar metabolites in these samples 
(Table S1 and Fig. S1). Polar metabolites were retained on 
the ZIC-cHILIC column and chromatographic separation 
was obtained (Fig. S1). For most of the metabolites, there 
was base-line separation and sensitivity was high enough 
to perform semi-quantitative analysis on the measured 
metabolites when using appropriate reconstructed ion chro-
matograms (Table S1). To determine ion suppression, we 
performed a post-column infusion experiment and did not 
observe any significant ion suppression (data not shown).
3.2  Endogenous and induced electrical activity 
affects metabolites in SCN and PVN tissue
To study the effect of time of day and of neuronal electrical 
activity in SCN and PVN tissue, we measured metabolites 
at two time-points, midday (ZT6) and midnight (ZT18), and 
in part of the brain slices we chemically manipulated the 
electrical activity. Intrinsic electrical activity in the SCN 
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is high during the day, and low during the night, and the 
electrical activity in the PVN has been found to be in phase 
with the SCN (Tousson and Meissl 2004). Neuronal activity 
was blocked at midday with tetrodotoxin (TTX). TTX blocks 
 Na2+-channels, preventing the initiation of action potentials, 
but does not affect membrane potential. Neuronal activity 
was induced at midnight by using increased extracellular  K+ 
concentrations, which depolarizes the neuronal membrane, 
increasing the chance of the initiation of action potentials.
In order to understand the effect of the changes in metab-
olite levels due to tissue treatment, we applied a PLS-DA 
analysis to the ZIC-cHILIC-MS dataset. This resulted in a 
clear separation of the night High  K+ group and to a lesser 
degree of the control day group from the TTX and control 
night group (Fig. 2a). The TTX and control night group 
could not be separated by the PLS-DA, which is not unex-
pected, since the TTX manipulation was intended to simu-
late the night conditions for neurons in the SCN and PVN. 
The heatmap in Fig. 2b represents the data for all the identi-
fied and measurable metabolites for all biological samples 
of this study, ordered on Variable Importance in Projection 
(VIP) score for the PLS-DA (Chong and Jun 2005). Interest-
ingly, all the intermediates of the TCA cycle were among the 
metabolites with the highest VIP score.
3.3  TCA cycle intermediates are upregulated 
after exposure to high extracellular  K+
Given the high VIP scores for the intermediates of the TCA 
cycle on the PLS-DA, we performed additional analysis on 
these metabolites (Fig. 3). From the metabolites directly 
involved in the TCA cycle, we could measure citrate, cis-
aconitate, succinate, fumarate and malate, which were all 
upregulated by exposure to high extracellular  K+, compared 
to the other groups, both in the SCN and PVN (citrate, cis-
aconitate, succinate, malate P < 0.0001, fumarate P < 0.01). 
Malate was significantly higher in the control-day group, 
compared to the control-night group (P < 0.5). Thus, upregu-
lating electrical activity by exposure to higher extracellular 
 K+ levels resulted in a strong upregulation of all measurable 
intermediates of the TCA cycle. In samples taken at midday 
compared to midnight, we could detect a significant differ-
ence for the TCA intermediate malate only.
4  Discussion
In this study we demonstrate the feasibility to measure 
metabolites in small tissue samples with ZIC-cHILIC-MS. 
We were able to semi-quantitatively measure 35 metabolites 
in the small tissue samples of the SCN and PVN (Table S1). 
Furthermore, we show that exposure of SCN and PVN tissue 
to high extracellular  K+ levels at night results in upregulation 
of many of the measured metabolites, and in particular of 
TCA cycle intermediates (Fig. 3; Figs. S2–S5).
Metabolites were measured in SCN and PVN tissue at 
midday (ZT6) and midnight (ZT18). In the SCN there is a 
strong circadian rhythm in neuronal activity, which peaks 
at midday and is lowest at midnight (Inouye and Kawamura 
1979; Sato and Kawamura 1984). In vitro MUA recordings 
in the PVN have shown that its neuronal activity depends 
on AVP released from the SCN, but that the rhythm of elec-
trical activity is in phase with that of the SCN (Tousson 
and Meissl 2004). To assess the impact of neuronal activity 
on metabolites, firing frequency was modulated in the SCN 
and PVN to simulate either a midday or midnight situation 
(Fig. 4). For this purpose, TTX was applied to silence the 
neurons of the SCN and PVN during the day, and elevated 
extracellular  K+ was applied to depolarize the neurons and 
increase firing frequency during the night. We found that the 
exposure to a higher  K+ concentration significantly upregu-
lated all measured intermediates of the TCA-cycle in both 
the SCN and PVN. This suggests a higher energy demand of 
the neurons, as is previously described (Shetty et al. 2012). 
Consequently, we expected glycolysis to be upregulated in 
these samples, however, no significant differences in glyco-
lysis intermediates was observed (Fig. S2). This indicates 
that different pathways from either fatty acids (fatty acid 
oxidation) or amino acids are used for energy metabolism 
under these conditions.
Only one of the measurable TCA cycle intermediates we 
found was significantly different between midday and mid-
night, and none were significantly different between midday 
and TTX treatment. This is surprising since cells are also 
more electrically active during the day than during the night 
or when silenced by with TTX (Shibata et al. 1984, 1982). 
However, the action potential frequency in SCN neurons 
is overall relatively low compared to other neurons, with a 
maximum of around 5 Hz during the day, and around 2.5 Hz 
during the night (Schaap et al. 1999). We do see a trend 
towards upregulation of the metabolites in the control-day 
group, compared to TTX treated and control-night samples 
(Fig. 2b). However, it is clear that high  K+ upregulates most 
of the metabolites we measured more severely than is the 
case for control-day vs TTX-day or control-night. An expla-
nation could be that there is a greater increase in electrical 
activity as a consequence of the manipulation with high  K+, 
compared to normal electrical activity at midday. This is per-
ceivable, since high  K+ pulses have been used to mimic light 
pulses (Eskin 1972; Mirmiran et al. 1995; Schwartz 1991), 
and light pulses can elicit a response in firing frequency up 
to 25 Hz in SCN neurons (Irwin and Allen 2007; Meijer 
et al. 1998). An additional explanation could be that there 
is a homeostatic control of energy metabolites to anticipate 
the change in energy demand from night to day. In that case 
silencing the neurons with TTX might have a minimal effect 
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on metabolite levels. Furthermore, individual neurons are 
naturally also inactive for a large proportion of the day; they 
are generally only active for about 5 h during daytime, and 
silent for the remaining 19 h (Schaap et al. 2003; Vander-
Leest et al. 2007).
The relatively strong response to the manipulation of 
electrical activity at midnight may be linked to the circa-
dian fluctuation in the sensitivity to light pulses (Meijer et al. 
1998). Light signals that reach the SCN from the eye through 
the RHT elicit electrical responses in SCN neurons. Experi-
ments both in vivo-with light exposure—as well as in vitro-
by electrically stimulating the RHT—have shown that this 
only results in a phase shift in behaviour or in the electrical 
activity rhythm when received during the subjective night, 
not when the same signal is received during the subjective 
day (Shirakawa and Moore 1994). It could be that the strong 
response in metabolite levels to increased electrical activity 
at midnight is a means for the cells to support intracellular 
signalling pathways that generate light-induced phase shifts 
of the molecular clock.
The absence of detectible differences between metabo-
lite levels at midday and midnight can have several reasons. 
First, if the peak and trough of the waveform is 6 h shifted 
from our sampling time points, there will be no differences 
detected. If the peak and trough are anywhere between 0 
and 6 h from the sampling time points, this will result in 
smaller differences between the two measurements. Fur-
thermore, the SCN and PVN are heterogeneous population 
of cells—including different types of neurons, as well as 
astrocytes—with diverse phases in their individual circadian 
rhythms (Abrahamson and Moore 2001; Brancaccio et al. 
2017; Enoki et al. 2017; Tasker and Dudek 1991). Therefore, 
metabolites that are rhythmic in single cells, can be arrhyth-
mic at the tissue level. Lastly, the one-hour incubation in 
ACSF may influence metabolite level in some unanticipated 
way. However, this is unlikely, since this incubation time 
does not affect rhythms in other physiological parameters of 
(SCN) neurons, like membrane potential, firing rate, intra-
cellular  Ca2+ levels or synaptic activity (Nakamura et al. 
2012).
In this study, we looked at static basic metabolism. To 
gain more information on the involvement of energy bal-
ance, metabolic flexibility and substrate specificity of the 
SCN and PVN tissue, it could be interesting to follow meta-
bolic fluxes by using isotopically stable labelled metabolites 
through the neuronal networks of the SCN and PVN under 
similar conditions as was described in this study. Using this 
technique, it would be possible to determine the real flux for 
the TCA cycle and which energy metabolites, glucose, fatty 
acids or amino acids, are involved for the energy utilization 
in neurons under high  K+ stimulation.
We show here that it is feasible to measure metabolites 
in small samples of brain tissue with a broadly applicable 
method, making it usable to tackle diverse biological ques-
tions. Using this method, we show that time of day, and 
manipulation of electrical activity affects metabolite levels 
in SCN and PVN tissue. Increasing electrical activity at mid-
night strongly upregulates metabolites of the TCA cycle. 
Our metabolomic study in the central circadian clock offers 
a unique view into the cellular biochemistry. Metabolites 
are not only a consequence of physiological states, they can 
actively influence cellular signalling pathways, including 
those involved in clock functioning. By combining this ana-
lytical tool with endogenous and exogenous modulation of 
neuronal activity, we were able to show the differential effect 
of these two sources of excitability on metabolites involved 
in cellular energy balance and signalling in the SCN.
Fig. 2  Global analysis of the complete data set. a An PLS-DA analy-
sis separated the high  K+-night group clearly, and to a lesser extend 
also separated the control-day group. The TTX-day and control-night 
groups largely overlap. Since silencing the neurons of the SCN with 
TTX at midday was intended to imitate the midnight state of the SCN 
this is in line with expectations. The results are similar for the SCN 
and PVN. b The contribution of the individual metabolites were cal-
culated from the PLS-DA, giving a value of the VIP. The metabolites 
are ordered on their VIP score and their relative amount per individ-
ual sample shown in a heat plot. Among the metabolites with high 
VIP scores are all measurable metabolites of the TCA cycle, and sev-
eral from the glycolysis pathway
◂
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Fig. 3  Metabolites of the TCA 
cycle are mainly affected by 
incubation in high  K+. a From 
the main metabolites of the 
TCA cycle, five were reliably 
measurable with the ZIC-
cHILIC-MS method (boxed). 
b In both the SCN and PVN, 
all these metabolites were 
significantly upregulated by 
incubation in high  K+-medium 
at midnight. In the SCN, there 
was higher level of malate in the 
control day group, compared 
to control night. *P < 0.05, 
**P < 0.01, ***P < 0.001
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